The increasing costs and complexity of R&D in the pharmaceutical industry have necessitated the adoption of strategic ...

His experience spans strategic planning, forecasting, market research, pricing and decision analysis. He is the author of Forecasting for the Pharmaceutical Industry (second edition; Gower ...

On the one hand, pharma has an urgent need to innovate in ... the result of 3 years experience-based observation, continuous analysis of the local and global contexts and permanent enrichment ...

Chromatography companies recognize significant opportunities in the biotech and pharma sectors, yet face uncertainty driven by rising tariffs and the growing integration of AI tools.

Treatments for autoimmune diseases and those in orphan markets are on the up and up, as are drugmakers’ first launches, ...

LEO Pharma A/S, a global leader in medical dermatology, today presented late-breaking data showcasing responses in a subgroup ...

In this review, GlobalData considers the products both approved and priced in 2024 and the factors that influenced their launch strategy.

For deeper insights into ATYR's valuation and growth prospects, consider exploring the detailed analysis available through InvestingPro's research platform. aTyr Pharma, like many clinical-stage ...